CommentaryAtherosclerosis

Atherosclerosis Drug Development in Jeopardy: The Need for Predictive Biomarkers of Treatment Response

See allHide authors and affiliations

Science Translational Medicine  02 Mar 2011:
Vol. 3, Issue 72, pp. 72cm6
DOI: 10.1126/scitranslmed.3002029

Article Information

vol. 3 no. 72 72cm6

DOI: 
https://doi.org/10.1126/scitranslmed.3002029
PubMed: 
21368220
Published By: 
American Association for the Advancement of Science
Print ISSN: 
1946-6234
Online ISSN: 
1946-6242
History: 
  • .
Copyright & Usage: 
Copyright © 2011, American Association for the Advancement of Science

Author Information

  1. David A. Fryburg1,*† and
  2. Maria T. Vassileva2,*
  1. 1ROI BioPharma Consulting, East Lyme, CT 06333, USA.
  2. 2The Biomarkers Consortium (BC), Foundation for the National Institutes of Health (FNIH), Bethesda, MD 20814, USA.
  3. *For the Atherosclerosis Working Group (AWG), a subcommittee of the Metabolic Disorders Steering Committee of the FNIH BC. Details of the AWG membership can be found in the acknowledgments.
  1. †Corresponding author. E-mail: dfryburg{at}roibiopharma.com

Altmetric

Article usage

Article usage: February 2011 to October 2020

AbstractFullPdf
Feb 20112941
Mar 20114238570274
Apr 20112756329
May 2011225831
Jun 2011195314
Jul 2011178013
Aug 2011149610
Sep 2011110411
Oct 201112759
Nov 2011152311
Dec 201190010
Jan 20129439
Feb 20128303
Mar 20129439
Apr 20129905
May 201211635
Jun 20126647
Jul 201281317
Aug 201228036
Sep 20127718
Oct 20127111
Nov 20124802
Dec 20126404
Jan 20139916
Feb 20136425
Mar 20136314
Apr 20139325
May 201312801
Jun 201311231
Jul 20136404
Aug 201374315
Sep 201374213
Oct 2013841120
Nov 201343737
Dec 201344138
Jan 2014711213
Feb 201452920
Mar 2014731414
Apr 2014591310
May 20145573
Jun 201445412
Jul 201434211
Aug 20143365
Sep 20144497
Oct 20143577
Nov 20143109
Dec 201426336
Jan 2015391016
Feb 20152635
Mar 20153344
Apr 201523612
May 2015171011
Jun 201521132
Jul 201518141
Aug 201535810
Sep 201511118
Oct 20151243
Nov 20151249
Dec 20151943
Jan 20162056
Feb 201615220
Mar 201622415
Apr 201614610
May 201618117
Jun 201622911
Jul 201620614
Aug 201622813
Sep 201630614
Oct 201624619
Nov 201628107
Dec 201620156
Jan 20171382
Feb 201721108
Mar 201721106
Apr 201721124
May 201722114
Jun 20171253
Jul 201722107
Aug 201735913
Sep 2017291013
Oct 201730114
Nov 201733166
Dec 201729135
Jan 2018281013
Feb 2018261014
Mar 201821158
Apr 201829237
May 2018353110
Jun 2018383319
Jul 2018141811
Aug 20183347
Sep 201844129
Oct 201815616
Nov 20180493
Dec 20180457
Jan 201942415
Feb 201992816
Mar 20197157
Apr 201952015
May 201931311
Jun 20192195
Jul 20192334
Aug 20191117
Sep 20192163
Oct 20193148
Nov 2019349
Dec 20194119
Jan 20204149
Feb 202071413
Mar 2020296
Apr 20202175
May 2020194
Jun 2020284
Jul 2020451
Aug 20201103
Sep 2020275
Oct 2020364

View Full Text

Article Tools

  • Email
  • Download Powerpoint
  • Print

  • Alerts
  • Citation tools

  • Atherosclerosis Drug Development in Jeopardy: The Need for Predictive Biomarkers of Treatment Response

    By David A. Fryburg, Maria T. Vassileva

    Science Translational Medicine : 72cm6

    The Atherosclerosis Working Group proposes the creation of an in silico model to identify biomarker panels for use in clinical trials.

    CiteULike logo Connotea logo del.icio.us logo Digg logo Facebook logo Google logo Mendeley logo Reddit logo Twitter logo

My saved folders

Stay Connected to Science Translational Medicine

Related Content

Similar Articles in:

Citing Articles in:

Navigate This Article